<<
>>

QUARANTINE AND HEALTH SCREENING

4.1 Quarantine

Quarantine is important in ex situ-breeding programs, both at establishment with the arrival of founder stock and for inter-institutional transfers. A period of 30 days has been recommended as a minimum standard duration (Woodford 2000); however, the DRA will generally guide the duration and level of isolation required for a given CT.

Where possible and ideally, animals in ex situ-breeding programs specifically for CTs should be held in perma­nent quarantine.

During the quarantine period animals typically undergo anaesthesia for comprehensive health evalua­tion, disease screening and application of a unique identi­fier such as a microchip transponder or ear tag. For CTs comprising direct wild to wild translocations, a period of in situ or ex situ quarantine maybe implemented. The duration of quarantine maybe determined by the length of time required for diagnostic testing to be completed or by the incubation period of specific diseases of concern. In addition to its obvious role as a disease mitigation strategy, quarantine also provides a period of acclimation before release, which may be particularly important in assisted colonisation programs. Given that quarantine has been associated with elevated FGMCs, for example in eastern bettongs (Batson et al. 2017), welfare considera­tions are also important in determining the length of the quarantine period.

4.2 Health and disease screening

Baseline health and disease data are unknown for many native mammal species. Performing comprehensive health evaluations serves several functions. It allows for baseline health and disease parameters to be established, which in turn can be used for the conservation manage­ment of the species. This data can then be used to inform disease risk analysis and mitigation strategies and forms the basis for longitudinal monitoring. Finally, health evaluations can be used as a basis for selecting candidates of an appropriate health status for CTs, thus maximising both conservation and welfare outcomes.

Health screening of conspecifics and sympatric spe­cies at the donor and recipient sites has been advocated to gain a broader understanding of potential disease effects. However, in reality logistical and resource constraints often dictate that health screening is limited to individu­als under direct consideration for CTs. Sympatric macro­pods were screened for a range of parasites and pathogens before reintroduction of brush-tailed rock-wallabies in the Grampians National Park, Vic. but there are few other examples of targeted surveillance of native mammal species at the recipient site before CT (Schultz et al. 2011).

Standardised assessment protocols and accurate record keeping are vital to ensure consistency throughout the process and for accurate comparisons during experimental evaluation of CT techniques. Anaesthesia is recommended for performing a complete physical examination and sample collection. Frequently, health and disease screening is carried out in remote locations, often at the point of cap­ture if the donor population is free-ranging, necessitating substantial forward planning to ensure successful field work (Fig. 2.2). Effective biosecurity protocols are also an important component of trapping, handling and sampling procedures to reduce the spread of pathogens and parasites and the possibility of cross-contamination of samples col­lected for disease screening (Hillman et al. 2016).

Deciding which diseases to screen for in CT programs will be influenced by the outcome of the DRA, the availa­bility of validated testing methodologies for a given patho­gen and species, the volume of blood and other biological samples that can be safely collected and logistical and cost limitations. Some disease processes with multifactorial aetiologies may be difficult to detect despite health screen­ing. For example, despite comprehensive pre-release oral cavity examinations in brush-tailed rock-wallabies several reintroduced animals succumbed to macropod progres­sive periodontal disease within 3 mo of release, suggesting early signs of the disease were not detected during health screening (Schultz et al.

2011).

Table 2.2. Selected diseases that may warrant consideration in disease risk analysis or disease investigation for macropod conservation translocations

Pathogen class Specific pathogens Disease screening and investigation testing options
Viruses Macropodid herpesviruses (MaHV-1, MaHV-2,

MaHV-3, MaHV-4, MaHV-5)

Potoroid herpesviruses (PotHV-1 and an incompletely described herpesvirus from brush-tailed bettongs [Bettongia penicillata])

Serum - serum-virus neutralisation assay (MaHV-1, MaHV-2 only, although may cross-react with other alphaherpesviruses) Conjunctival, nasal, oropharyngeal and urogenital swabs - pan­herpesvirus PCR

Fresh tissue - virus isolation, PCR

Orbiviruses (Wallal, Warrego, Eubenangee serogroups) Serum - serum-virus neutralisation assay (Wallal and Warrego serogroups only)

Formalin-fixed tissue samples - PCR, immunohistochemistry Fresh tissue samples - virus isolation, PCR

Papillomaviruses (including B. penicillata papillomavirus type 1 [BpPV1]) Fresh or frozen skin samples - PCR
Encephalomyocarditis virus Serum - serum neutralisation test Tissue samples - virus isolation
Uncharacterised pox viruses Skin biopsy - histopathology
Bacteria Bordetella bronchiseptica Nasal swabs, tracheal wash, bronchoalveolar lavage - bacterial culture
Salmonella spp., Campylobacter spp., Yersinia pseudotuberculosis Tissue samples, faeces - bacterial culture
Treponema spp.
- Gilbert's potoroo (Potorous gilbertii)
Urogenital swabs - bacterial culture, dark-field microscopy
Coxiella burnetii Faecal sample - qPCR

Serum - complement fixation test, ELISA

Erysipelothrix rhusiopathiae Tissue samples - bacterial culture
Leptospira spp. Serum - microscopic agglutination test, indirect haemagglutination assay, microsphere immunoassay, ELISA Urine - dark-field microscopy, culture, PCR
Mycobacterium spp. (typically, managed animals) Tissue aspirates, bronchoalveolar lavage samples - acid-fast stains, culture and PCR

Tissue samples - histopathology, culture and PCR

Clostridium tetani, C. perfringens Tissue samples - bacterial culture
Burkoholderia pseudomallei Whole blood and/or serum - culture using selective media, biochemical tests, latex agglutination assays, PCR

Tissue samples - culture using selective media, PCR

Fungi Cryptococcus spp. (potoroids in particular) Serum - LCAT, cryptococcal antigen lateral flow assay Cerebrospinal fluid - LCAT

Tissue samples - culture, PCR

Protozoa Toxoplasma gondii Serum - modified agglutination test, indirect fluorescent antibody test, ELISA

Fresh/frozen tissue - PCR

Formalin-fixed tissue - histopathology, immunohistochemistry, PCR

Eimeria spp., Isospora spp. Faeces - faecal flotation
Neospora caninum Serology -cELISA and N.
caninum-agglutination test Tissue - histopathology, immunohistochemistry, PCR

Pathogen class Specific pathogens Disease screening and investigation testing options
Protozoa (cont.) Trypanosoma spp. (T. copemani, T. noyesi, T. vegrandis, uncharacterised Trypanosoma spp.) Blood smears - cytology (low sensitivity)

Whole blood - PCR combined with Sanger sequencing

Babesia macropus Blood smears, brain and kidney impression smears - cytology Tissue - histopathology, PCR
Leishmania spp. PCR on tissue or blood samples

Serology - indirect fluorescent antigen test and ELISA

Besnoitia spp. Nasal smears - cytology

Tissue samples - histopathology

Theileria spp.

(T. gilberti, T. penicillata, T. brachyuri, T. fuliginosa, uncharacterised Theileria spp.)

Blood smears - light microscopy (low sensitivity) Whole blood - PCR targeting the 18S rRNA gene
Helminths Various GI nematodes

Potentially pathogenic spp. include third- stage larvae of Labiomultiplex spp., Labiosimplex spp. and Rugopharynx rosemariae (eastern [Macropusgiganteus] and western [M. fuliginosus] grey kangaroos only); Strongyloides spp.; Globocephaloides spp.; and Hypodontus macropi

Identification of parasites obtained at necropsy; speciation of nematode eggs presents in faeces is generally not possible
Fasciola hepatica Faeces - faecal sedimentation techniques Identification of parasites obtained at necropsy
Echinococcus granulosa Pulmonary cysts may be identified radiographically Identification of parasites obtained at necropsy
Angiostrongylus cantonensis Fresh brain or meninges - microscopy

Fixed brain - histopathology

Arthropods Sarcoptes scabiei Skin scrapings - microscopy
Thadeua spp. Skin scrapings - microscopy
Ixodes spp., Haemaphysalis spp., Amblyomma spp. Clinical examination
Non-infectious disease Exertional myopathy Blood - biochemistry (CK, AST etc.) Formalin-fixed tissue - histopathology

Table 2.3.

Selected diseases that may warrant consideration in disease risk analysis or disease investigation for koala (Phascolarctos cinereus) conservation translocations
Pathogen class Specific pathogens Disease screening and investigation testing options
Viruses Koala retroviruses (KoRV-A, KoRV-B, KoRV-J, and numerous subtypes)

Phascolarctid herpesviruses (PhaHV-1, PhaHV-2)

Papillomaviruses

Blood, faeces, tissue - PCR

Conjunctival, nasal, oropharyngeal and urogenital swabs - pan-herpesvirus PCR Fresh tissue - virus isolation, PCR

Tissue - histopathology, PCR

Bacteria Chlamydia pecorum, C. pneumoniae

Coxiella burnetii

Conjunctival and urogenital swabs - PCR Formalin-fixed tissue - immunohistochemistry Faecal sample - qPCR

Serum - complement fixation test, ELISA

Fungi Cryptococcus gatti, C. neoformans Serum - LCAT, cryptococcal antigen lateral flow assay Cerebrospinal fluid - LCAT

Tissue samples - culture, PCR

Protozoa Trypanosoma irwini, T. gilletti, T. copemani, T. vergrandis Blood smears - cytology (low sensitivity)

Whole blood - PCR combined with Sanger sequencing

Helminths Durikainema phascolarcti Tissue samples - histopathology
Arthropods Koalachirus perkinsi

Sarcoptes scabiei

Fur pluck samples - microscopy

Skin scrapings - microscopy

Non-infectious disease Oxalate nephrosis Urine - urinalysis Ultrasonography

Fig. 2.2. Field set up for health evaluation of bush rats (Rattus fuscipes) during a reintroduction program. Photo: Larry Vogelnest

Table 2.4. Selected diseases that may warrant consideration in disease risk analysis or disease investigation for wombat conservation translocations

Pathogen class Specific pathogens Disease screening and investigation testing options
Viruses Vombatid herpesviruses (VoHV-1,

VoHV-2, VoHV-3)

Encephalomyocarditis virus

Conjunctival, nasal, oropharyngeal and urogenital swabs - pan herpesvirus PCR Fresh tissue - virus isolation, PCR

Serum - serum neutralisation test

Tissue samples - virus isolation

Bacteria Leptospira spp. Including L. interrogans serovar Pomona Serum - microscopic agglutination test, indirect haemagglutination assay, microsphere immunoassay, ELISA

Urine - dark-field microscopy, culture, PCR

Fungi Emmonsia parva Formalin-fixed tissue - histopathology, PCR Fresh tissue - fungal culture, PCR
Protozoa Toxoplasma gondii

Eimeria arundeli, E. wombati,

E. ursini

Trypanosoma spp.

Serum - modified agglutination test, indirect fluorescent antibody test, ELISA Fresh/frozen tissue - PCR

Formalin-fixed tissue - histopathology, immunohistochemistry, PCR

Faeces - faecal flotation

Blood smears - cytology (low sensitivity) Whole blood - PCR combined with Sanger sequencing

Helminths Echinococcus granulosus

Baylisascaris tasmaniensis

Strongyloides speari

Fasciola hepatica

Typically diagnosed at necropsy

Pulmonary cysts may be identified radiographically Identification of parasites obtained at necropsy Faeces - Baermann technique

Faeces - faecal sedimentation techniques

Identification of parasites obtained at necropsy

Arthropods Sarcoptes scabiei

Aponomma auruginans, Ixodes spp., Echidnophaga spp.

Skin scrapings - PCR or microscopic examination

Clinical examination

Table 2.5. Selected diseases that may warrant consideration in disease risk analysis or disease investigation for dasyurid conservation translocations

Pathogen class Specific pathogens Disease screening and investigation testing options
Viruses Herpesviruses (DaHV-1, DaHV-2, DaHV-3 and an undescribed gammaherpesvirus from eastern quolls [Dasyurus viverrinus]) Conjunctival, nasal, oropharyngeal and urogenital swabs - pan­herpesvirus PCR
Bacteria Bacillus cereus - managed dibblers (Parantechinus apicalis) Faeces - bacterial culture
Salmonella spp. including S. mississippi,

S. potsdam, S. freemantle

Faeces - bacterial culture
Campylobacter jejuni Faeces - bacterial culture
Mycobacterium spp. (cutaneous disease in managed animals) Swabs and fresh tissue - mycobacterial culture, acid-fast staining, PCR
Leptospira spp. including L. borgpetersenii serovar Javanica, L. weilli serovar Cellodoni Serum - microscopic agglutination test, indirect haemagglutination assay, microsphere immunoassay, ELISA

Urine - dark-field microscopy, culture, PCR

Coxiella burnetii Faecal sample -qPCR

Serum - complement fixation test, ELISA

Fungi Cryptococcus spp. Serum - LCAT, cryptococcal antigen lateral flow assay Cerebrospinal fluid - LCAT

Tissue samples - culture, PCR

Protozoa Sarcocystis mucosa Formalin-fixed tissue - histopathology
Haemogregarina dasyuri, Hepatazoon dasyuri Blood smear - microscopy

Whole blood - PCR

Toxoplasma gondii Serum - modified agglutination test, indirect fluorescent antibody test, ELISA

Fresh/frozen tissue - PCR

Formalin-fixed tissue - histopathology, immunohistochemistry, PCR

Trypanosoma copemani Blood smears - cytology (low sensitivity)

Whole blood - PCR combined with Sanger sequencing

Giardia spp. Faeces - wet preparation, centrifugal faecal flotation, immunofluorescence microscopy, PCR
Babesia spp. Blood smears - cytology Tissue - histopathology, PCR
Helminths Trichinella pseudospiralis (Tas. only) Formalin-fixed tissue - histopathology
Baylisascaris tasmaniensis Faeces - faecal flotation
Ophidascaris robertsi Identification of parasites obtained at necropsy Formalin-fixed tissue - histopathology
Cercopithifilaria johnstoni Identification of parasites obtained at necropsy Formalin-fixed tissue - histopathology
Arthropods Ixodes spp., Pygiopsylla hoplia, Uropsylla tasmanica Clinical examination
Dasyurochirus major, Demodex spp., Myocoptes spp. Skin scrapes, fur pluck - microscopy
Neoplasia Devil facial tumour disease Clinical examination

Formalin-fixed tissue - histopathology, immunohistochemistry

Table 2.6. Selected diseases that may warrant consideration in disease risk analysis or disease investigation for possum and glider conservation translocations

Pathogen class Specific pathogens Disease screening and investigation testing options
Viruses Wobbly possum disease - common brush-tailed possum (Trichosurus vulpecula); unknown if a nidovirus is the aetiological agent in Australia Tissue samples - RT-qPCR
Papillomavirus Fresh or frozen skin samples - PCR
Uncharacterised pox viruses Skin biopsy - histopathology
Brush-tailed possum adenovirus (PoAdV-1), described from possums in NZ Intestinal contents - PCR
Gammaherpesviruses in yellow-bellied glider and Leadbeater's possums Ocular, cloacal, nasal oropharyngeal swabs - universal herpesvirus PCR
Bacteria Coxiella burnetii Faecal sample - qPCR

Serum - complement fixation test, ELISA

Clostridium piliforme Tissue samples - bacterial culture, histopathology and silver staining
Mycobacterium ulcerans Tissue samples - histopathology, culture and PCR Faecal samples - PCR
Yersinia pseudotuberculosis Tissue samples - bacterial culture
Lepstospira spp. including L. interrogans serovar Balcanica Serum - microscopic agglutination test, indirect haemagglutination assay, microsphere immunoassay, ELISA Urine - dark-field microscopy, culture, PCR
Francisella tularensis ssp. holarctica biovar japonica Liver - culture, direct fluorescent antigen testing, PCR
Staphylococcus aureus - implicated in exudative dermatitis of common brush-tailed possums (T. vulpecula) and swollen paw syndrome of eastern ring-tailed (Pseudocheirusperegrinus), although both diseases likely have a multifactorial aetiology Direct swabs - bacterial culture
Listeria monocytogenes Tissue samples - bacterial culture
Fungi Emmonsia crescens Formalin-fixed tissue - histopathology, PCR Fresh tissue - fungal culture, PCR
Protozoa Toxoplasma gondii Serum - modified agglutination test, indirect fluorescent antibody test, ELISA

Fresh/frozen tissue - PCR

Formalin-fixed tissue - histopathology, immunohistochemistry, PCR

Cryptosporidium parvum Faeces - acid-fast staining, direct fluorescent antibody test
Giardia intestinalis Faeces - wet preparation, centrifugal faecal flotation, immunofluorescence microscopy, PCR

Serum - ELISA

Plasmodium spp. - Leadbeater's possum (Gymnobelideus leadbeateri) Blood smear - microscopy

Whole blood - PCR

Helminths Angiostrongylus cantonensis Fresh brain or meninges - microscopy

Fixed brain - histopathology

Anoplotaenia dasyuri, Bertiella trichosuri, Marsupostrongylus minesi, Parastrongyloides trichosuri Identification of parasites obtained at necropsy
Trichinellapseudospiralis (Tasmania only) Formalin-fixed tissue - histopathology
Arthropods Trichosurolaelaps crassipes, Echidnophagia myrmecobii, Notoedres muris, Ixodes spp. Clinical examination or skin scrape samples - microscopy

Table 2.7. Selected diseases that may warrant consideration in disease risk analysis or disease investigation for bandicoot and greater bilby (Macrotis lagotis) conservation translocations

bgcolor=white>Serum - modified agglutination test, indirect fluorescent antibody test, ELISA

Fresh/frozen tissue - PCR

Formalin fixed tissue - histopathology, immunohistochemistry, PCR

Pathogen class Specific pathogens Disease screening and investigation testing options
Viruses Bandicoot papillomatosis carcinomatosis viruses

(BPCV)

BPCV-1 - western barred bandicoot (Perameles bougainville)

BPCV-2 - southern brown bandicoot (Isoodon obesulus)

Skin swabs, fresh or frozen biopsy samples - PCR Formalin-fixed biopsies - histopathology and in situ hybridisation
Peramelid herpesvirus-1 Conjunctival, nasal, oropharyngeal and urogenital swabs - pan-herpesvirus PCR
Encephalomyocarditis virus Serum - serum neutralisation test Tissue samples - virus isolation
Bacteria Coxiella burnetii Faecal sample - qPCR

Serum - complement fixation test, ELISA

Erysipelothrix rhusiopathiae Tissue samples - bacterial culture
Chlamydia spp. Conjunctival and urogenital swabs - PCR Formalin-fixed tissue - immunohistochemistry
Mycobacterium spp.

M. ulcerans

Direct swabs, tissue samples or faeces - culture and/or PCR
Salmonella spp., Campylobacter spp. Faeces - bacterial culture
Leptospira spp.

L. interrogans serovar Perameles, L. weilii serovar Topaz

Serum - microscopic agglutination test, indirect haemagglutination assay, ELISA

Urine - dark-field microscopy, culture, PCR

Fungi Cryptococcus spp. Serum - LCAT, cryptococcal antigen lateral flow assay Cerebrospinal fluid - LCAT

Tissue samples - culture, PCR

Protozoa Toxoplasma gondii
Cryptosporidium spp.

C. muris - managed greater bilbies (Macrotis lagotis)

Faeces - acid-fast staining, direct fluorescent antibody test
Giardia spp.

G. peramelis

Faeces - wet preparation, centrifugal faecal flotation, immunofluorescence microscopy, PCR

Serum - ELISA

Eimeria spp.

E. kanyana - western barred bandicoot

Faeces - faecal flotation
Hepatozoon spp. Blood smear - microscopy

Whole blood - PCR

Babesia spp. Blood smears - cytology Tissue - histopathology, PCR
Trypanosoma spp. Blood smears - cytology Whole blood - PCR
Helminths Asymmetracantha tasmaniensis, Gnathostoma spp., Capillaria spp., Parastrongyloides australis, Paremelostrongylus spp., Physalaptera peramelis, Moniliformis semoni Faeces - zinc sulfate faecal flotation to identify capillarid and spirurid ova

Recovery of helminths at necropsy for identification

Pathogen class Specific pathogens Disease screening and investigation testing options
Helminths (cont.) Cercopithifilaria johnstoni Identification of parasites obtained at necropsy Formalin-fixed tissue - histopathology
Arthropods Ixodes spp., Pygiopsylla hoplia, Pygiopsyllazethi, Haemolaelaps marsupialis, Sarcoptes scabiei, Schoutedenichia emphyla, Stephanocircus daysuri, Petauralges spp., Ornithonyssus bacoti Clinical examination or skin scrape samples - microscopy

5.

<< | >>
Source: Vogelnest L., Portas T. (Eds.). Current Therapy in Medicine of Australian Mammals. CSIRO,2025. — 848 p.. 2025

More on the topic QUARANTINE AND HEALTH SCREENING: